Chinese General Practice ›› 2021, Vol. 24 ›› Issue (17): 2140-2147.DOI: 10.12114/j.issn.1007-9572.2021.00.115
Special Issue: 泌尿系统疾病最新文章合集; 老年问题最新文章合集
• Monographic Research • Previous Articles Next Articles
Published:
2021-06-15
Online:
2021-06-15
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.00.115
[1]United Nations,Department of Economic and Social Affairs,Population Division (2019World Population Prospects 2019:Highlights).[M].UN,New York,2019:3-11. [2]国家统计局.中华人民共和国2019年国民经济和社会发展统计公报[J].中国统计,2020,(3):8-22. National Bureau of Statistics.Statistical Bulletin of the People's Republic of China on the 2019 National Economic and Social Development[J].China Statistics,2020,(3):8-22. [3]BARNETT K,MERCER S W,NORBURY M,et al.Epidemiology of multimorbidity and implications for health care,research,and medical education:a cross-sectional study[J].Lancet,2012,380(9836):37-43.DOI:10.1016/S0140-6736(12) 60240-2. [4]WASTESSON J W,MORIN L,TAN E C K,et al.An update on the clinical consequences of polypharmacy in older adults:a narrative review[J].Expert Opin Drug Saf,2018,17(12):1185-1196.DOI:10.1080/14740338.2018.1546841. [5]O'SULLIVAN E D,HUGHES J,FERENBACH D A.Renal aging:causes and consequences[J].J Am Soc Nephrol,2017,28(2):407-420.DOI:10.1681/ASN.2015121308. [6]KLOTZ U.Pharmacokinetics and drug metabolism in the elderly[J].Drug Metab Rev,2009,41(2):67-76. [7]AWDISHU L,MEHTA R L.The 6R's of drug induced nephrotoxicity[J].BMC Nephrol,2017,18(1):124.DOI:10.1186/s12882-017-0536-3. [8]MEHTA R L,AWDISHU L,DAVENPORT A,et al.Phenotype standardization for drug-induced kidney disease[J].Kidney Int,2015,88(2):226-234.DOI:10.1038/ki.2015.115. [9]HUANG L,XUE C,KUAI J,et al.Clinical characteristics and outcomes of community-acquired versus hospital-acquired acute kidney injury:a meta-analysis[J].Kidney Blood Press Res,2019,44(5):879-896.DOI:10.1159/000502546. [10]HIMMELFARB J,IKIZLER T A.Acute kidney injury:changing lexicography,definitions,and epidemiology[J].Kidney Int,2007,71(10):971-976.DOI:10.1038/sj.ki.5002224. [11]JHA V,MALHOTRA H S,SAKHUJA V,et al.Spectrum of hospital-acquired acute renal failure in the developing countries—Chandigarh study[J].Q J Med,1992,83(303):497-505. [12]MAHAJAN S,TIWARI S,BHOWMIK D,et al.Factors affecting the outcome of acute renal failure among the elderly population in India:a hospital based study[J].Int Urol Nephrol,2006,38(2):391-396.DOI:10.1007/s11255-006-0053-y. [13]KOHLI H S,BHAT A,ARAVINDAN A N,et al.Predictors of mortality in elderly patients with acute renal failure in a developing country[J].Int Urol Nephrol,2007,39(1):339-344. [14]KOHLI H S,BHASKARAN M C,MUTHUKUMAR T,et al.Treatment-related acute renal failure in the elderly:a hospital-based prospective study[J].Nephrol Dial Transplant,2000,15(2):212-217.DOI:10.1093/ndt/15.2.212. [15]BARALDI A,BALLESTRI M,RAPANÀ R,et al.Acute renal failure of medical type in an elderly population[J].Nephrol Dial Transplant,1998,13(Suppl 7):25-29.DOI:10.1093/ndt/13.suppl_7.25. [16]NASH K,HAFEEZ A,HOU S.Hospital-acquired renal insufficiency[J].Am J Kidney Dis,2002,39(5):930-936.DOI:10.1053/ajkd.2002.32766. [17]LI Q,ZHAO M,DU J,et al.Outcomes of renal function in elderly patients with acute kidney injury[J].Clin Interv Aging,2017,12:153-160.DOI:10.2147/CIA.S121823. [18]SESSO R,ROQUE A,VICIOSO B,et al.Prognosis of ARF in hospitalized elderly patients[J].Am J Kidney Dis,2004,44(3):410-419. [19]HSU C N,LEE C T,SU C H,et al.Incidence,outcomes,and risk factors of community-acquired and hospital-acquired acute kidney injury:a retrospective cohort study[J].Medicine (Baltimore),2016,95(19):e3674.DOI:10.1097/MD.0000000000003674. [20]MARKOWITZ G S,BOMBACK A S,PERAZELLA M A.Drug-induced glomerular disease:direct cellular injury[J].Clin J Am Soc Nephrol,2015,10(7):1291-1299.DOI:10.2215/CJN.00860115. [21]INUI K I,MASUDA S,SAITO H.Cellular and molecular aspects of drug transport in the kidney[J].Kidney Int,2000,58(3):944-958.DOI:10.1046/j.1523-1755.2000.00251.x. [22]TIONG H Y,HUANG P,XIONG S,et al.Drug-induced nephrotoxicity:clinical impact and preclinical in vitro models[J].Mol Pharm,2014,11(7):1933-1948.DOI:10.1021/mp400720w. [23]HOGAN J J,MARKOWITZ G S,RADHAKRISHNAN J.Drug-induced glomerular disease:immune-mediated injury[J].Clin J Am Soc Nephrol,2015,10(7):1300-1310.DOI:10.2215/CJN.01910215. [24]DAUDON M,FROCHOT V,BAZIN D,et al.Drug-induced kidney stones and crystalline nephropathy:pathophysiology,prevention and treatment[J].Drugs,2018,78(2):163-201.DOI:10.1007/s40265-017-0853-7. [25]Al-NOURI Z L,REESE J A,TERRELL D R,et al.Drug-induced thrombotic microangiopathy:a systematic review of published reports[J].Blood,2015,125(4):616-618. [26]PERAZELLA M A.Pharmacology behind common drug nephrotoxicities[J].Clin J Am Soc Nephrol,2018,13(12):1897-1908.DOI:10.2215/CJN.00150118. [27]陈伟,刘华锋.抗菌药物相关急性肾损伤的新认识[J].临床合理用药杂志,2010,3(1):124-126.DOI:10.15887/j.cnki.13-1389/r.2010.01.099 CHEN W,LIU H F.New understanding of acute kidney injury related to antibiotics[J].Chinese Journal of Clinical Rational Drug Use,2010,3(1):124-126.DOI:10.15887/j.cnki.13-1389/r.2010.01.099. [28]HUO X,LIU K.Renal organic anion transporters in drug-drug interactions and diseases[J].Eur J Pharm Sci,2018,112:8-19.DOI:10.1016/j.ejps.2017.11.001. [29]DENIC A,GLASSOCK R J,RULE A D.Structural and functional changes with the aging kidney[J].Adv Chronic Kidney Dis,2016,23(1):19-28.DOI:10.1053/j.ackd.2015.08.004. [30]LINDEMAN R D,TOBIN J,SHOCK N W.Longitudinal studies on the rate of decline in renal function with age[J].J Am Geriatr Soc,1985,33(4):278-285.DOI:10.1111/j.1532-5415.1985.tb07117.x. [31]IMAI E,HORIO M,YAMAGATA K,et al.Slower decline of glomerular filtration rate in the Japanese general population:a longitudinal 10-year follow-up study[J].Hypertens Res,2008,31(3):433-441.DOI:10.1291/hypres. [32]HOMMOS M S,GLASSOCK R J,RULE A D.Structural and functional changes in human kidneys with healthy aging[J].J Am Soc Nephrol,2017,28(10):2838-2844.DOI:10.1681/ASN.2017040421. [33]JOCHEMSEN R,NANDI K L,CORLESS D,et al.Pharmacokinetics of brotizolam in the elderly[J].Br J Clin Pharmacol,1983,16(Suppl 2):299S-307S.DOI:10.1111/j.1365-2125.1983.tb02304.x. [34]SOENEN S,RAYNER C K,JONES K L,et al.The ageing gastrointestinal tract[J].Curr Opin Clin Nutr Metab Care,2016,19(1):12-18.DOI:10.1097/MCO.0000000000000238. [35]ROBERTS A G,GIBBS M E.Mechanisms and the clinical relevance of complex drug-drug interactions[J].Clin Pharmacol,2018,10:123-134.DOI:10.2147/CPAA.S146115. [36]UPADHYA B,TAFFET G E,CHENG C P,et al.Heart failure with preserved ejection fraction in the elderly:scope of the problem[J].J Mol Cell Cardiol,2015,83:73-87.DOI:10.1016/j.yjmcc.2015.02.025. [37]REINDERS I,VISSER M,SCHAAP L.Body weight and body composition in old age and their relationship with frailty[J].Curr Opin Clin Nutr Metab Care,2017,20(1):11-15.DOI:10.1097/MCO.0000000000000332. [38]MAKIZAKO H,SHIMADA H,DOI T,et al.Age-dependent changes in physical performance and body composition in community-dwelling Japanese older adults[J].J Cachexia Sarcopenia Muscle,2017,8(4):607-614.DOI:10.1002/jcsm.12197. [39]HANRATTY C G,MCGLINCHEY P,JOHNSTON G D,et al.Differential pharmacokinetics of digoxin in elderly patients[J].Drugs Aging,2000,17(5):353-362.DOI:10.2165/00002512-200017050-00003. [40]TAJIRI K,SHIMIZU Y.Liver physiology and liver diseases in the elderly[J].World J Gastroenterol,2013,19(46):8459-8467.DOI:10.3748/wjg.v19.i46.8459. [41]DOAN J,ZAKRZEWSKI-JAKUBIAK H,ROY J,et al.Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy[J].Ann Pharmacother,2013,47(3):324-332.DOI:10.1345/aph.1R621. [42]BURRIS J F,TORTORICI M A,MANDIC M,et al.Dosage adjustments related to young or old age and organ impairment[J].J Clin Pharmacol,2016,56(12):1461-1473.DOI:10.1002/jcph.816. [43]CORSONELLO A,PEDONE C,INCALZI R A.Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions[J].Curr Med Chem,2010,17(6):571-584.DOI:10.2174/092986710790416326. [44]SCONDOTTO G,POJERO F,POLLINA ADDARIO S,et al.The impact of polypharmacy and drug interactions among the elderly population in Western Sicily,Italy[J].Aging Clin Exp Res,2018,30(1):81-87.DOI:10.1007/s40520-017-0755-2. [45]王烁烁,许丽雅,陈长香,等.社区老年人经济地位与医疗负担对老年人用药行为影响[J].中国公共卫生,2020,36(10):1429-1432.DOI:10.11847/zgggws1123929. WANG S S,XU L Y,CHEN C X,et al.Influence of economic condition and medical burden on medication behaviors among community elderly people[J].Chinese Journal of Public Health,2020,36(10):1429-1432.DOI:10.11847/zgggws1123929. [46]马翔宇,侯宁.老年人潜在不适当用药调查分析[J].中国医院用药评价与分析,2019,19(8):1017-1020.DOI:10.14009/j.issn.1672-2124.2019.08.036. MA X Y,HOU N.Investigation and analysis of potential inappropriate drug application among the elderly[J].Evaluation and Analysis of Drug-Use in Hospitals of China,2019,19(8):1017-1020.DOI:10.14009/j.issn.1672-2124.2019.08.036. [47]何淑莹,梁文汉,赵新生,等.Beers标准评价某基层医院门诊心血管内科老年人用药[J].中国现代药物应用,2019,13(8):153-155.DOI:10.14164/j.cnki.cn11-5581/r.2019.08.090. HE S Y,LAING W H,ZHAO X S,et al.Beers standard evaluation of drugs used by the elderly in the cardiovascular department of a primary hospital[J].Chinese Journal of Modern Drug Application,2019,13(8):153-155.DOI:10.14164/j.cnki.cn11-5581/r.2019.08.090. [48]高翔,黄婷,陈杰,等.老年高血压住院患者潜在不适当用药调查[J].中国老年学杂志,2019,39(5):1223-1226.DOI:10.3969/j.issn.1005-9202.2019.05.063. GAO X,HUANG T,CHEN J,et al.Investigation of potential inappropriate medications in elderly hypertensive inpatients[J].Chinese Journal of Gerontology,2019,39(5):1223-1226.DOI:10.3969/j.issn.1005-9202.2019.05.063. [49]CHARLESWORTH C J,SMIT E,LEE D S,et al.Polypharmacy among adults aged 65 years and older in the united states:1988—2010[J].J Gerontol A Biol Sci Med Sci,2015,70(8):989-995.DOI:10.1093/gerona/glv013. [50]GUTHRIE B,MAKUBATE B,HERNANDEZ-SANTIAGO V,et al.The rising tide of polypharmacy and drug-drug interactions:population database analysis 1995—2010[J].BMC Med,2015,13:74.DOI:10.1186/s12916-015-0322-7. [51]BOURGEOIS F T,SHANNON M W,VALIM C,et al.Adverse drug events in the outpatient setting:an 11-year national analysis[J].Pharmacoepidemiol Drug Saf,2010,19(9):901-910.DOI:10.1002/pds.1984. [52]LAZAROU J,POMERANZ B H,COREY P N.Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies[J].JAMA,1998,279(15):1200-1205.DOI:10.1001/jama.279.15.1200. [53]CLASSEN D C,PESTOTNIK S L,EVANS R S,et al.Adverse drug events in hospitalized patients.Excess length of stay,extra costs,and attributable mortality[J].JAMA,1997,277(4):301-306. [54]HANLON J T,SCHMADER K E,RUBY C M,et al.Suboptimal prescribing in older inpatients and outpatients[J].J Am Geriatr Soc,2001,49(2):200-209.DOI:10.1046/j.1532-5415.2001.49042.x. [55]於亚洲,卢振,张丽芳,等.黄石市社区老年人用药依从性现状及影响因素研究[J].中国药业,2019,28(3):90-92.DOI:10.3969/j.issn.1006-4931.2019.03.029. YU Y Z,LU Z,ZHANG L F,et al.Study on the current situation and influencing factors of medication compliance of the elderly in a community in Huangshi City[J].China Pharmaceuticals,2019,28(3):90-92.DOI:10.3969/j.issn.1006-4931.2019.03.029. [56]王秋梅,闫雪莲,刘晓红,等.老年人用药依从性及其相关影响因素分析[J].中国临床保健杂志,2018,21(2):148-152.DOI:10.3969/J.issn.1672-6790.2018.02.002. WANG Q M,YAN X L,LIU X H,et al.Medication adherence and the related influential factors among the elderly patients[J].Chinese Journal of Clinical Healthcare,2018,21(2):148-152.DOI:10.3969/J.issn.1672-6790.2018.02.002. [57]郭志钢,王涵,吕霁航,等.老年人安全用药情况国内外对比研究[J].长春中医药大学学报,2019,35(1):185-187,192.DOI:10.13463/j.cnki.cczyy.2019.01.054. GUO Z G,WANG H,LYU J H,et al.Comparison of proper usage of medicines for elderly between China and foreign countries[J].Journal of Changchun University of Traditional Chinese Medicine,2019,35(1):185-187,192.DOI:10.13463/j.cnki.cczyy.2019.01.054. [58]钟运香,卢锐辉,何碧娟,等.药师应用SOAP药历对药源性肾损伤患者的药学监护[J].中国医院用药评价与分析,2019,19(5):622-624.DOI:10.14009/j.issn.1672-2124.2019.05.033. ZHONG Y X,LU R H,HE B J,et al.Pharmaceutical care for patients with drug-induced renal injury by clinical pharmacists with application of SOAP medication record[J].Evaluation and Analysis of Drug-Use in Hospitals of China,2019,19(5):622-624.DOI:10.14009/j.issn.1672-2124.2019.05.033. |
[1] | FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358. |
[2] | GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238. |
[3] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[4] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[5] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[6] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[7] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[8] | CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun. Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(31): 3890-3895. |
[9] | ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889. |
[10] | DUAN Yanqin, PENG Ying, LIU Shenglan, LIU Haijiao, YANG Huiqiong, HU Haiqing. Prevalence and Associated Factors of Potentially Inappropriate Medication among Elderly Outpatients [J]. Chinese General Practice, 2023, 26(31): 3902-3907. |
[11] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
[12] | PAN Yaojia, WANG Weiqiang, YI Weizhuo, GAO Bing, FU Fanglin, HAN Zheng, SUN Meng, DONG Yaqin, GU Huaicong. Relationship between Triglyceride-glucose Index and Risk of Cardiovascular Diseases in Middle-aged Obese Residents of Different Genders [J]. Chinese General Practice, 2023, 26(29): 3628-3635. |
[13] | ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649. |
[14] | ZHAO Xiaohua, DU Lin, GAO Shengnan, JIANG Ziyun. Multiple Deep Muscle Abscesses in Type 2 Diabetes in the Elderly: Report of One Case and Literature Review [J]. Chinese General Practice, 2023, 26(29): 3715-3718. |
[15] | ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||